Transfusion of Biotin-Labeled Red Blood Cells
Clinical trial NCT03364686 · TERMINATED
Trial details
- NCT number
- NCT03364686
- Sponsor
- Gladwin, Mark, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-16
- Primary completion
- 2021-03-02
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.